MEPHEDRONE
Synthetic cathinone stimulant-empathogen with short duration and high abuse liability, linked to fatalities.
Mephedrone emerged as a recreational drug in Europe around 2007 and quickly became a significant public health concern. Controlled studies and forensic data show blood concentrations in fatal cases are approximately 11 times higher than in non-fatal cases, with a narrow therapeutic window. Its acute toxicity profile resembles other stimulants such as MDMA, amphetamine, and cocaine, though its duration of action is significantly shorter, driving binge use patterns. The neurotoxic potential appears lower than MDMA in animal studies, but the abuse liability is significantly greater. Long-term effects remain poorly characterized given the drug's relatively recent emergence. Poly-drug use, particularly with alcohol and other depressants, is common among users and complicates toxicological interpretation.